NB-PP_1170x120

Scott Gottlieb

Gottlieb resigns as FDA commissioner

Gottlieb resigns as FDA commissioner

SILVER SPRING, Md. — Food and Drug Administration Commissioner Scott Gottlieb is resigning, effective in about a month. The 46-year-old Gottlieb, who has been commuting weekly to the FDA office here from his home in Connecticut, wants to spend more time with his family, an administration official told The Washington Post. Health and Human Services

CRN praises FDA’s commitment to increased enforcement action

CRN praises FDA’s commitment to increased enforcement action

WASHINGTON — In response to a statement published by Scott Gottlieb, Commissioner, Food and Drug Administration on February 11, the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, issued the following statement: Statement by Steve Mister, president and chief executive officer at CRN: “CRN appreciates the

CRN welcomes formation of FDA dietary supplement working group

CRN welcomes formation of FDA dietary supplement working group

WASHINGTON – In response to an announcement made by Scott Gottlieb, commissioner, Food & Drug Administration (FDA) at the Food and Drug Law Institute Enforcement, Litigation and Compliance Conference on December 12, the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, Steve Mister, president and chief

Retail sales ban expected on flavored e-cigarettes

Retail sales ban expected on flavored e-cigarettes

SILVER SPRING, Md. — Seeking to curb vaping by minors, the Food and Drug Administration is banning retail sales of most flavored e-cigarettes. FDA Commissioner Scott Gottlieb early this month was on the verge of announcing the prohibition (which will exempt menthol and mint flavors), as well as imposing age-verification requirements for online e-cigarette sales.

Dr. Reddy’s gets FDA approval, launches generic version of Suboxone

Dr. Reddy’s gets FDA approval, launches generic version of Suboxone

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories announced today that it has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching buprenorphine and naloxone sublingual film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone (buprenorphine and

FDA: Work to boost flu vaccine effectiveness under way

FDA: Work to boost flu vaccine effectiveness under way

SILVER SPRING, Md. — The Food and Drug Administration has begun efforts to improve flu vaccine effectiveness, according to FDA commissioner Scott Gottlieb. In a statement released yesterday, Gottlieb cited less protection against the influenza A H3N2 virus as a chief reason for the low efficacy of the 2017-2018 flu vaccine. The Centers for Disease

FDA cracks down on rogue online pharmacies

FDA cracks down on rogue online pharmacies

SILVER SPRINGS, Md. — The Food and Drug Administration has clamped down on hundreds of websites engaged in illegal sales of prescription drugs. The FDA said Monday that, in tandem with international regulatory and law enforcement agencies, actions were taken against more than 500 websites selling potentially dangerous, unapproved versions of prescription medicines — including

Scott Gottlieb takes reins as FDA commissioner

Scott Gottlieb takes reins as FDA commissioner

WASHINGTON — Dr. Scott Gottlieb has been sworn in as the new commissioner of the Food and Drug Administration. Gottlieb, nominated as FDA commissioner by President Donald Trump in March, took the helm as the FDA’s 23rd commissioner on Thursday after being confirmed by a vote of 57-42 in the Senate late Tuesday. He takes